Isoprostane activation of the nuclear hormone receptor PPAR

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 351-355

  McNamara, Peter ^a   Lawson, John A ^a   Rokach, Joshua ^b   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Florida Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; HORMONE RECEPTOR; ISOPROSTANE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; RETINOIC ACID; CELL RECEPTOR; ISOPROSTANE DERIVATIVE; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; BINDING AFFINITY; CERCOPITHECIDAE; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC TRANSFECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; TRANSACTIVATION; ANIMAL; ARTICLE; CELL LINE; CERCOPITHECUS; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALIA; CERCOPITHECIDAE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ISOPROSTANES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS;

EID: 0037769655     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_54     Document Type: Conference Paper

References (25)

1. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ, Non-cyclooxygenase- derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 89(22):10721-5 (1992).
2. Awad JA, Morrow JD, Takahashi K, Roberts LJ, Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma, J Biol Chem. 268(6):4161-9 (1993).
3. Pratico D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA, IPF2alpha-I: an index of lipid peroxidation in humans, Proc Natl Acad Sci U S A. 95(7):3449-54 (1998).
4. Meagher, EA and FitzGerald GA, The Endothelium in Clinical Practice: Isoprostanes and Antioxidant Therapy in Human Diseases (Rbanyi, GM and Dzau VJ eds) pp. 413-438 Marcel Dekker Inc. New York (1997).
5. Pratico D, F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo, Atherosclerosis. 141(1):1-10 (1999).
6. Pratico D, Lee V, Trojanowski JQ, Rokach J, Fitzgerald GA, Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo, FASEB J. 12(15):1777-83 (1998)
7. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, FitzGerald GA, Localization of distinct F2-isoprostanes in human atherosclerotic lesions, J Clin Invest. 100(10):2637 (1997)
8. Reilly MP, Pratico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, FitzGerald GA Increased formation of distinct F2 isoprostanes in hypercholesterolemia, Circulation. 98(25):2822-8 (1998).
9. Kunapuli P, Lawson JA, Rokach J, FitzGerald GA, Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha, J Biol Chem. 272(43):27147-54 (1997).
10. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA, Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice, Nat Med. 4(10):1189-92 (1998).
11. Michalik L, Wahli W, Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions. Curr Opin Biotechnol. 10(6):564-70 (1999).
12. Kliewer SA, Lehmann JM, Milburn MV, Willson TM, The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways. Recent Prog Harm Res. 54:345-67 (1999).
13. Desvergne B, Wahli W, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr Rev. 20(5):649-88 (1999)
14. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma, Proc Natl Acad Sci U S A. 94(9):4318-23 (1997).
15. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages, J Biol Chem. 2;273(40):25573-80 (1998).
16. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palinski W, Glass CK Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc Natl Acad Sci U S A. 23;95(13):7614-9 (1998).
17. Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM Jr, Nicholson AC, Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma, J Biol Chem. 275(2):1241-6 (2000).
18. Bishop-Bailey D, Peroxisome proliferator-activated receptors in the cardiovascular system, Br J Pharmacol. 5;129(5):823-834 (2000).
19. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL, Cell. 93(2):229-40 (1998).
20. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM, Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma, Cell. 93(2):240-259 (1998).
21. Marx N, Schonbeck U, Lazar MA, Libby P, Plutzky J, Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells, Circ Res. 83(11):1097-103 (1998).
22. Poynter ME, Daynes RA, Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging, J Biol Chem. 4;273(49):32833-41 (1998).
23. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A, Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators, Nature. 393(6687):790-3 (1998).
24. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell. 83(5):803-12 (1995)
25. Forman BM, Chen J, Evans RM, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta, Proc Natl Acad Sci U S A. 94(9):4312-7 (1997).